141 filings
8-K
RNAC
Cartesian Therapeutics Inc
22 Apr 24
Other Events
6:25am
8-K
RNAC
Cartesian Therapeutics Inc
9 Apr 24
Regulation FD Disclosure
7:00am
8-K
RNAC
Cartesian Therapeutics Inc
1 Apr 24
Departure of Directors or Certain Officers
4:32pm
8-K
RNAC
Cartesian Therapeutics Inc
28 Mar 24
Cartesian Therapeutics Announces Approval of Conversion of Series A Convertible Preferred Stock and Plans to Effect Reverse Stock Split
5:00pm
8-K
RNAC
Cartesian Therapeutics Inc
14 Mar 24
Termination of a Material Definitive Agreement
7:55am
8-K
muxk7
7 Mar 24
Cartesian Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
7:06am
8-K
k5m9hw alamkl74ca
5 Mar 24
Entry into a Material Definitive Agreement
7:05am
8-K/A
w9nwox2rl
23 Jan 24
Independent Auditor’s Report
4:05pm
8-K
txeafik6oizfdp
19 Jan 24
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:12pm
8-K
if432t1a18l5xz4
8 Jan 24
Regulation FD Disclosure
8:45am
8-K
y60nky6n8jvq qsedwsz
27 Nov 23
Departure of Directors or Certain Officers
4:18pm
8-K
24bs9ru7okqnf6gbtm
13 Nov 23
Entry into a Material Definitive Agreement
9:02am
8-K
7g01kuz9 o4twxn1p
31 Oct 23
Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi
4:06pm
8-K
kf3z j87xztknsuotw
25 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
9969t3sm
13 Sep 23
Other Events
7:33am
8-K
xvlwgjry30v4l6a83
17 Aug 23
Results of Operations and Financial Condition
7:10am
8-K
06jajcmj
16 Jun 23
Submission of Matters to a Vote of Security Holders
4:20pm
8-K
6o4yvy36fpi qjciivg9
4 Apr 23
Entry into a Material Definitive Agreement
4:16pm
8-K
m6xa9h 88n8nxf
21 Mar 23
Regulation FD Disclosure
8:30am
8-K
x7rv4v
9 Jan 23
Selecta Biosciences and Astellas Announce Exclusive Licensing and Development Agreement for Xork IgG Protease
8:05am